Rosenbrock J, Kaul H, Oertel M, Celik E, et al. Involved-site radiotherapy is equally effective and less toxic than Involved-field radiotherapy in patients receiving combined modality treatment for early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase III HD17 trial of the Int J Radiat Oncol Biol Phys 2024 Apr 15:S0360-3016(24)00514.
PMID: 38631539